Abstract

This article examines the modern approach to the treatment of arterial hypertension as one of the most important medical and social problems in the developed world, characterised by a high prevalence high risk of cardiovascular complications and occurrence along with comorbid diseases.

Highlights

  • Summary This article examines the modern approach to the treatment of arterial hypertension as one of the most important medical and social problems in the developed world, characterised by a high prevalence high risk of cardiovascular complications and occurrence along with comorbid diseases

  • Summary The article presents an overview of the literature on the choice of pharmacotherapy of arterial hypertension (AH)

  • This article focuses on the properties and effects of olmesartan, that distinguish it from other ARBs

Read more

Summary

Introduction

Место блокаторов рецепторов ангиотензина II 1-го типа в современной терапии артериальной гипертонии. Бисопролол более эффективен, чем метопролол, при лечении АГ, особенно у пациентов, ведущих активный образ жизни. Исследование по сравнению эффективности бисопролола (10 мг/сут) и ИАПФ эналаприла (20 мг/сут) с участием 57 больных с мягкой и умеренной АГ, показало, что бисопролол обладает несколько более выраженной гипотензивной активностью.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.